Non-Hodgkin lymphoma is the 6th most common cancer in the UK, accounting for 4% of all new cancer cases (2015).[1-4]
In males in the UK, non-Hodgkin lymphoma is the 7th most common cancer (4% of all new male cancer cases). In females in the UK it is the 7th most common cancer (4% of all new female cancer cases).
55% of non-Hodgkin lymphoma cases in the UK are in males, and 45% are in females.
Non-Hodgkin lymphoma incidence rates (European
Non-Hodgkin Lymphoma (C82-C86), Number of New Cases, Crude and European Age-Standardised (AS) Incidence Rates per 100,000 Population, UK, 2015
|AS Rate - 95% LCI||26.9||20.9||21.1||21.2||26.2|
|AS Rate - 95% UCI||28.2||24.8||26.1||28.4||27.5|
|AS Rate - 95% LCI||19.1||16.3||15.7||14.3||18.8|
|AS Rate - 95% UCI||20.1||19.4||19.7||19.8||19.7|
|AS Rate - 95% LCI||22.8||18.8||18.8||18.4||22.4|
|AS Rate - 95% UCI||23.6||21.3||21.9||22.9||23.1|
For non-Hodgkin lymphoma, there are few established risk factors therefore differences between countries largely reflect differences in diagnosis and data recording.
- Data were provided by the Office for National Statistics on request, July 2017. Similar data can be found here: https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/cancerregistrationstatisticsengland/previousReleases.
- Data were provided by ISD Scotland on request, August 2017. Similar data can be found here: http://www.isdscotland.org/Health-Topics/Cancer/Publications.
- Data were provided by the Welsh Cancer Intelligence and Surveillance Unit, Health Intelligence Division, Public Health Wales on request, October 2017. Similar data can be found here: http://www.wcisu.wales.nhs.uk.
- Data were provided by the Northern Ireland Cancer Registry on request, July 2017. Similar data can be found here: http://www.qub.ac.uk/research-centres/nicr/.
About this data
Data is for UK, 2015, ICD-10 C82-C86.
The term 'non-Hodgkin lymphoma' describes a large group of lymphoma subtypes, which differ substantially in their cellular origin and clinical behaviour. The subtypes can be broadly divided into B-cell lymphomas, T-cell lymphomas, and lymphoproliferative disorders not otherwise specified. B-cell lymphomas can be further divided into five main types: diffuse large B-cell lymphoma, marginal zone lymphomas, follicular lymphoma, mantle cell lymphoma, and Burkitt lymphoma. It is important to recognise the variation between these subtypes when interpreting statistics on NHL as a whole. The Haematological Malignancy Research Network provides detailed incidence statistics for NHL subtypes.